The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
students
companies founded by graduates and faculty in the last 10 years
among universities worldwide for producing undergrad entrepreneurs
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
For over two decades, his laboratory has sought to understand how a small regulatory protein known as ubiquitin relates to the progression of Alzheimer’s disease. Ubiquitin’s functions are essential for cell cycle regulation, DNA repair, and protein quality control. When ubiquitin attaches to a protein — in a process known as “ubiquitin signaling” — it influences the protein’s activity, location, or interactions. Prof. Glickman’s lab has made significant progress in understanding how defects in this process may contribute to the onset of sporadic Alzheimer’s disease (the most common form of the condition, which occurs randomly in the population without a clear, singular genetic cause). The lab combines biochemical expertise with cutting-edge cell-biological approaches and advanced tissue culture techniques.
A native of Sweden, Prof. Glickman began his research journey studying enzymes as a doctoral student at UC Berkeley, followed by postdoctoral work in cell biology at Harvard Medical School, which laid the foundation for his career investigating protein quality control mechanisms. In addition to a Ph.D. in Chemistry and Enzymology from UC Berkeley, he holds a B.Sc. in Chemistry from the Hebrew University of Jerusalem.
His numerous accolades include the Schmidt Futures award from the Eric Schmidt Foundation for Nascent Research, the Diane Sherman Prize for Medical Innovation for a Better World from the Technion, and the Bessel Research Award from the Humboldt Foundation in Germany. He has held visiting appointments at the Max Delbruck Center in Berlin, the University of Maryland – College Park, the Institut Jacques Monod and U. Diderot in Paris, and the National Cancer Institute.
Prof. Glickman has served as a member of the Faculty of Biology at the Technion since 1999 and is a former vice dean of the faculty.
Alzheimer’s disease is one of the greatest medical and societal challenges of our time. The progressive brain disorder now affects millions of families worldwide, and the number of cases is expected to rise as populations age. At the Technion, groundbreaking research is challenging conventional thinking about the disease and opening new avenues that could lead […]
Could a mistake actually be the start of something great? In this surprising talk, Prof. Hemi Rotenberg shares the story of a “scientific screwup” that changed everything. What started as a mishap in the lab led his team to discover a revolutionary optoelectronic material that can now pace hearts and modulate nerves using nothing but […]
Why do so many life-saving technologies never make it out of the lab? Prof. Marcelle Machluf demonstrates how combining scientific rigor with business vision is the only way to bring practical solutions to the patients who need them most. As a case in point, she shares her personal transformation from researcher to entrepreneur. This talk […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.